194 related articles for article (PubMed ID: 29134272)
21. Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations.
Kępa L; Oczko-Grzesik B; Sobala-Szczygieł B; Boroń-Kaczmarska A
Przegl Epidemiol; 2015; 69(4):705-10, 851-5. PubMed ID: 27139348
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic relevance of the chemokine CXCL13 and anti-C6 peptide antibodies in patients with neuroborreliosis].
Pícha D; Moravcová L; Smíšková D
Epidemiol Mikrobiol Imunol; 2017; 66(2):80-85. PubMed ID: 28691831
[TBL] [Abstract][Full Text] [Related]
23. Chemokine CXC Ligand 13 in Cerebrospinal Fluid Can Be Used as an Early Diagnostic Biomarker for Lyme Neuroborreliosis: A Meta-Analysis.
Yang J; Han X; Liu A; Bao F; Peng Y; Tao L; Ma M; Bai R; Dai X
J Interferon Cytokine Res; 2017 Oct; 37(10):433-439. PubMed ID: 28972436
[TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.
Bremell D; Mattsson N; Edsbagge M; Blennow K; Andreasson U; Wikkelsö C; Zetterberg H; Hagberg L
BMC Neurol; 2013 Jan; 13():2. PubMed ID: 23294475
[TBL] [Abstract][Full Text] [Related]
25. Discriminating between Lyme neuroborreliosis and other central nervous system infections by use of biomarkers CXCL13 and IL-6.
Leth TA; Dessau RB; Møller JK
Ticks Tick Borne Dis; 2022 Sep; 13(5):101984. PubMed ID: 35709639
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid CXCL13 in non-borrelial central nervous system infections: contribution of CXCL13 to the differential diagnosis.
Smíšková D; Džupová O; Moravcová L; Pícha D
Infect Dis (Lond); 2023 Aug; 55(8):551-558. PubMed ID: 37317698
[TBL] [Abstract][Full Text] [Related]
27. Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.
van Burgel ND; Bakels F; Kroes AC; van Dam AP
J Clin Microbiol; 2011 May; 49(5):2027-30. PubMed ID: 21367992
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I
APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
[TBL] [Abstract][Full Text] [Related]
30. Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections.
Pícha D; Moravcová L; Smíšková D
J Neurol Sci; 2016 Sep; 368():214-20. PubMed ID: 27538636
[TBL] [Abstract][Full Text] [Related]
31. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
[TBL] [Abstract][Full Text] [Related]
32. [CXCL-13 as a biomarker in the diagnostics of neuroborreliosis].
Waiß C; Kindler W; Ströbele B; Aspöck C; Oberndorfer S
Nervenarzt; 2017 Jun; 88(6):635-641. PubMed ID: 28184973
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity and specificity of cerebrospinal fluid CXCL13 for diagnosing Lyme neuroborreliosis - a study on 1410 patients and review of the literature.
Lintner H; Hochgatterer-Rechberger P; Pischinger B; Seier J; Vollmann P; Haushofer A; Rittner H; Sommer C; Topakian R
J Neurol Sci; 2020 Jul; 414():116843. PubMed ID: 32344220
[TBL] [Abstract][Full Text] [Related]
35. CXCL13 in laboratory diagnosis of Lyme neuroborreliosis-the performance of the recomBead and ReaScan CXCL13 assays in human cerebrospinal fluid samples.
Haglund S; Lager M; Gyllemark P; Andersson G; Ekelund O; Sundqvist M; Henningsson AJ
Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):175-179. PubMed ID: 34626256
[TBL] [Abstract][Full Text] [Related]
36. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.
Rupprecht TA; Plate A; Adam M; Wick M; Kastenbauer S; Schmidt C; Klein M; Pfister HW; Koedel U
J Neuroinflammation; 2009 Dec; 6():42. PubMed ID: 20042073
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid cytokines in Lyme neuroborreliosis.
Pietikäinen A; Maksimow M; Kauko T; Hurme S; Salmi M; Hytönen J
J Neuroinflammation; 2016 Oct; 13(1):273. PubMed ID: 27756335
[TBL] [Abstract][Full Text] [Related]
38. CXCL13 in patients with facial palsy caused by varicella zoster virus and Borrelia burgdorferi: a comparative study.
Lindström J; Bremell D; Grahn A; Blennow K; Zetterberg H; Studahl M
Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115095. PubMed ID: 32610209
[TBL] [Abstract][Full Text] [Related]
39. Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis?
Tumani H; Cadavid D
Neurology; 2011 Mar; 76(12):1034-5. PubMed ID: 21422454
[No Abstract] [Full Text] [Related]
40. The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis.
Dersch R; Hottenrott T; Senel M; Lehmensiek V; Tumani H; Rauer S; Stich O
Fluids Barriers CNS; 2015 May; 12():12. PubMed ID: 25975424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]